LifeMD (LFMD) Prices 3.33M Share Offering of Common Stock at $6/Each

LifeMD, Inc. (the “Company”) (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced the pricing of its previously announced underwritten registered public offering of 3,333,334 shares of its common stock, par value $0.01 per share, for gross proceeds of approximately $20 million at a public offering price of $6.00 per share of common stock, prior to deducting underwriting discounts and commissions and estimated offering expenses. In connection with this offering, the Company has granted the underwriters a 30-day option to purchase 500,000 additional shares of common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on October 4, 2021, subject to customary closing conditions.

The Company intends to use the net proceeds from this offering to repay a portion of its indebtedness and the remaining net proceeds for working capital and general corporate purposes including, but not limited to, new patient customer acquisition expenses and capital expenditures.

B. Riley Securities, Inc. is acting as the sole book-running manager for the offering.

You May Also Be Interested In

• Holcim to acquire Fermacell from James Hardie for EUR 840M
• Profusa reports Q2 2026 loss, advances G3 Vision Labs deal
• LivePerson adjourns stockholder vote on SoundHound AI merger to Sept. 2